Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

36.73 -0.35 (-0.94%)
Streaming Delayed Price Updated: 2:25 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
28 29 Next >
News headline image
Peering Into Viking Therapeutics's Recent Short Interest ↗
 
Via Benzinga
News headline image
Unleashing the Bulls: 3 Top Stocks to Charge Ahead in March ↗
This environment presents a compelling opportunity for investors seeking growth. Discover 3 top stocks primed for long-term growth in 2024. 
Via InvestorPlace
News headline image
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market? ↗
Viking aims to enter a market that may be worth $100 billion in a few years. 
Via The Motley Fool
News headline image
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant ↗
The pharma giant could have yet another knockout obesity drug on the way. 
Via The Motley Fool
News headline image
What's Going On With Viking Therapeutics (VKTX) Stock? ↗
Viking Therapeutics shares are trading lower by 10.9% Monday afternoon. The stock has experienced marked volatility following a number of key company announcements in February. 
Via Benzinga
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have $900 Today ↗
 
Via Benzinga
News headline image
Is Viking Therapeutics Stock a Buy? ↗
Its potential is looking increasingly more likely to be realized. 
Via The Motley Fool
News headline image
Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock. ↗
Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest. 
Via The Motley Fool
News headline image
3 Stock Winners That Are Up 1,000% or More in 2024 ↗
Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three. 
Via InvestorPlace
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Viking Therapeutics Stock Is Plunging Today ↗
The sell-off could present a buying opportunity for aggressive investors willing to bet that the obesity market will be big enough for multiple winners. 
Via The Motley Fool
News headline image
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. 
Via Benzinga
News headline image
Novo Nordisk Jumps On Strong Results For New Weight-Loss Drug ↗
Amycretin showed a 13.1% weight loss after 12 weeks in a phase 1 trial. 
Via Investor's Business Daily
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
The Ozempic craze continues to make headlines in the medical sector, and GLP-1 drug stocks such as Vivani Medical continue to surge higher 
Via MarketBeat
News headline image
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News? ↗
A new player in the multibillion-dollar weight-loss drug market could be waiting in the wings. 
Via The Motley Fool
News headline image
A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried? ↗
Here's why I'm not worried. 
Via The Motley Fool
News headline image
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly ↗
One is a reigning champion, and the other is a burgeoning contender. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
1 Wall Street Analyst Thinks Viking Therapeutics Stock Is Going to $116. Is It a Buy Around $81? ↗
It could have even further to rise after its massive run-up. 
Via The Motley Fool
News headline image
Beyond the "Mag 7": 3 Risk-On Market Forces ↗
The biggest bear argument over the past year has been slim leadership in the market, namely concentrated in mega-cap tech stocks such as the “Mag 7.” However, dig deeper, and you will discover there's... 
Via Talk Markets
News headline image
Better Buy: Eli Lilly vs. Viking Therapeutics ↗
These two biotechs could eventually go head to head in a fast-growing market. 
Via The Motley Fool
News headline image
Missed Out on Novo Nordisk Stock? Buy This 1 Biotech Stock Right Now. ↗
The battle for the obesity therapies market is escalating. 
Via The Motley Fool
News headline image
Why Novo Nordisk Stock Topped the Market Today ↗
A favorite of both investors and analysts gets a boost from a bullish move by a pundit. 
Via The Motley Fool
News headline image
Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review ↗
The Nasdaq is on the cusp of setting a record high. 
Via Investor's Business Daily
Topics Economy
News headline image
Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion ↗
Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says. 
Via Investor's Business Daily
News headline image
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years ↗
It will take a lot, but this goal isn't out of reach for these stocks. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.